Chipiron

• The FUTURE-AI Consortium of 117 experts from 50 countries created a framework around fairness, universality, traceability, usability, robustness,...

Experts Wendie Berg, Manisha Bahl, and Amy Patel discuss autonomous AI's potential to ease radiologist shortages in breast imaging.

• They cover...

Professor Wing Cheong Chow highlighted mammography limitations for Asian women due to denser breasts and earlier peak incidence, urging combined...

Fujifilm and Beekley Medical’s third annual Breast Imaging Education Summit delivered complimentary training on supplemental screening, AI...

After a benign breast fibrosis biopsy, radiologic-pathologic concordance and personal risk determine the plan.

• Concordant pure fibrosis: Return to...

The BI-RADS v2025 update revises the status of contrast-enhanced mammography, which was previously considered a supplementary modality.

Grant success for devices and diagnostics hinges on more than prototypes.

• Clinical evidence: Unmet need tied to study design, endpoints, and named...

A new family breast cancer diagnosis calls for professional risk assessment using personal history, genetics, and validated models to guide tailored...

Nanox reported preliminary Q3 2026 revenue of $4.3–4.4 million, up from $3.4 million, with AI/software jumping to $1.0 million after acquiring Nanox...

Expert-level results in select medical tasks do not confirm that large AI models behave equitably across demographic groups or clinical settings. The...

Does the 0.2T-1.2T MRI market's projected 4.2% CAGR through 2035 truly deliver validated, affordable, and accessible clinical applications?

• Market...

Mammography anchors average-risk screening by detecting calcifications and delivering proven mortality reduction, while MRI supplements it for...

New Mexico’s Breast and Cervical Cancer Early Detection Program offers free screenings and diagnostic tests for low-income uninsured women through...

The UK government has accepted continuous lifecycle monitoring for AI-enabled medical devices, shifting from one-time assessments to ongoing...

European trials are shifting AI evaluation from detection counts to interval cancers, follow-up burden and screening capacity.

• MASAI showed AI...

UPMC Hamot’s 20th MammoMarathon offered walk-in screenings without appointments or insurance, plus incentives like prizes and therapy dogs, to...

Inherited mutations in genes like BRCA1/2 often signal the need for high-risk breast screening such as MRI, yet standard risk models relying on family...

A normal mammogram result does not erase the effects of dense breasts, which can both hide cancers and raise risk independently.

• Density...

Does a prestigious innovation award confirm real-world gains in imaging access—or just strong positioning?

• Award focus: TIME recognized Nanox.ARC X...

Philips' dedicated closed-design breast coil emphasizes performance and patient experience in MRI.

• Image performance: Optimized for high...